New study in Oncotarget shows that stable aneuploid cells are more sensitive to TTK inhibition than chromosomally unstable cell lines
Stable aneuploid tumor cells are more sensitive to small molecule inhibitors of TTK than chromosome instable cells.
Read more
New at Pivot Park: PerkinElmer OneSource
Since mid-February OneSource is a new occupant in the Pivot Park community.
Read more
Regenerative medicine crossing borders
Osteo-Pharma will take part in the five-year project focusing on taking steps towards a bioengineered joint.
Read more
RA2day: addressing today’s regulatory topics
Zwiers Regulatory Consultancy is organising RA2day on April 7th 2017.
Read more
New at Pivot Park: MSD Animal Health
MSD Animal Health, formerly known as Intervet, is one of the companies that became part of the Pivot Park Community.
Read more
PharmSupport betrekt kantoor op Pivot Park
H. Lundbeck A/S (Lundbeck) and Prexton Therapeutics BV (Prexton) announced March 16th the signing of a definitive agreement in which Lundbeck will acquire Prexton.
Read more
Staten stemmen in met financiële steun Pivot Park Oss
Provinciale Staten hebben ingestemd met het voorstel om eenmalig extra financiering beschikbaar te stellen aan het Pivot Park in Oss.
Read more
Pivot Park verwelkomt 500-ste werknemer
Met de komst van Noviocell heeft Pivot Park de 500-ste werknemer op de open innovatie campus verwelkomd.
Read more
BioConnection ontvangt een voucher van de Kracht van New Business Oss
Vrijdag 13 januari was een feestelijke dag voor BioConnection. Zij ontvingen een voucher ter waarde van € 20.000 van de Kracht van New Business Oss.
Read more